Arguably the best way to make money investing in stocks is to buy them at the right price. If you do that, generating positive returns is practically a slam dunk.

With this in mind, we asked three Motley Fool contributors to identify dirt-cheap pharmaceutical stocks that they think investors should buy sooner rather than later. Here's why they chose Bristol Myers Squibb (NYSE: BMY), Pfizer (NYSE: PFE), and Viatris (NASDAQ: VTRS).

Prosper Junior Bakiny (Bristol Myers Squibb): Sometimes, a  pharmaceutical company like Bristol Myers Squibb can be viewed by investors as "boring." Whether that's a fair view or not, though, it's hard to argue with results, and Bristol Myers Squibb did something few corporations managed to pull off in the past year; it beat the market and stayed in the green. 

Continue reading

Source Fool.com